Oxford Sigma has returned to Oxford’s city centre to accelerate fusion materials technology commercialisation to help tackle climate change and resolve energy security, with new global headquarters at The Oxford Trust’s Oxford Centre for Innovation.
Detailed designs for three new, prestigious laboratory and office buildings which total 458,100 sq ft (42,549 sq m) and will be built as phase 2 of Oxford North, the new £700 million life sciences innovation district, have been resolved to be approved by Oxford City Council’s planning committee.
INTERTRONICS supplies adhesives, coatings, sealants and equipment to customers with high technology, high-performance assembly applications. Our customers are manufacturers in industries such as electronics, medical devices, plastics, optical, automotive, energy, defence and aerospace.
For more than two years Northern Ireland has faced difficulties trading with the wider UK. The 2020 Northern Ireland Protocol established systems for trade in and out of Northern Ireland, but has led to a mass of practical difficulties both in the flow of goods across the Irish Sea, and legal compliance for businesses operating […]
A new approach to the use of precision genetic technology in plants and animals has recently been introduced in England. This will make is easier to use advanced DNA editing methods like CRISPR-Cas9 in the agrifood sector.
Universities and spin-out companies should be reviewing their general position in relation to intellectual property ownership in light of the court’s decision in the recent case of Oxford University Innovations v Oxford Nanoimaging 2022.
The EU Clinical Trials Regulation (EU) 536/2014 (the CTR) became applicable on 31 January 2022. We asked our best friend firm in Germany, Graf von Westphalen, to give us an insight into how the CTR and the related Clinical Trials Information System (CTIS) are bedding in.
A recent ABPI report highlighted a decline in UK clinical trials. Improving the UK ecosystem for clinical research will involve a range of measures, and we look forward to publication of the O’Shaughnessy review. This sits alongside an ongoing substantial upgrade to UK clinical trials legislation and guidance, that forms the focus of this article.
As Culham Innovation Centre in south Oxfordshire celebrates 22 years of providing flexible workspace for innovators in the science sector, the innovation centre is also reflecting on its contribution to cutting-edge technology that is helping to deliver potentially world-changing solutions.
Oxford Innovation Space manages the largest network of innovation centres across the UK, managing 25 centres currently with a further seven in the pipeline. With the scale and pace of growth, Oxford Innovation Space has taken the strategic decision to divide its business development portfolio into public sector clients and science and technology clients, creating new senior roles to set the benchmark and continue the growth trajectory.
Biotech start-up Samsara Therapeutics, an early-stage drug discovery company, has expanded into a further 1,000 sq ft of R&D lab space at The Oxford Trust’s Wood Centre for Innovation in Headington, Oxford’s Health and Life Sciences District to accommodate company growth.